Jiangsu Kanion Pharmaceutical Co.,Ltd. (SHA:600557)
China flag China · Delayed Price · Currency is CNY
14.42
+0.17 (1.19%)
Feb 3, 2026, 3:00 PM CST

SHA:600557 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
2,1572,1951,9791,601937.44768.81
Trading Asset Securities
-404601701764.5
Cash & Short-Term Investments
2,1572,2352,4391,7711,113773.31
Cash Growth
0.73%-8.36%37.70%59.08%43.98%89.05%
Accounts Receivable
630.91700.541,0921,4711,3501,616
Other Receivables
3.36.335.489.6711.759.82
Receivables
634.21706.871,0981,4801,3621,626
Inventory
445.23540.27350.11342.82338.08376.53
Other Current Assets
64.82113.69188.65135.3260.91110.3
Total Current Assets
3,3023,5964,0763,7302,8742,886
Property, Plant & Equipment
2,8912,7522,5392,5082,5332,557
Long-Term Investments
11.3315.3415.3245.6160.6473.63
Goodwill
58.9958.9958.9958.9958.9958.99
Other Intangible Assets
203.62171.46198.17231.15282.73340.79
Long-Term Deferred Tax Assets
47.7145.3146.2215.9616.7717.68
Long-Term Deferred Charges
202.96203.84192.67184.79171.14164.69
Other Long-Term Assets
22.9964.462.8121.6320.7220.14
Total Assets
6,7406,9077,1896,7966,0186,119
Accounts Payable
210.33226.87236.61373.36359.75281
Accrued Expenses
20.32880.741,030814.57531.14528.47
Short-Term Debt
----234.5488
Current Income Taxes Payable
60.652.142.422.12.055.33
Current Unearned Revenue
22.8325.4625.17214.8725.3426.5
Other Current Liabilities
1,338909.27748.41376.2300.08366.75
Total Current Liabilities
1,6522,0442,0421,7811,4531,696
Long-Term Debt
1.931.931.931.931.931.93
Long-Term Unearned Revenue
172.56155.27126.1678.7890.5293.81
Total Liabilities
1,8272,2022,1711,8621,5451,792
Common Stock
566.16581.8584.75584.6592.88592.88
Additional Paid-In Capital
--178.2998.13171.79174.57
Retained Earnings
4,1484,1454,2254,1363,7203,399
Treasury Stock
--211.98-48.14-64.7-180-
Total Common Equity
4,7144,5154,9404,7544,3044,167
Minority Interest
198.57190.5178.47179.8168.35160.13
Shareholders' Equity
4,9134,7055,0194,9344,4734,327
Total Liabilities & Equity
6,7406,9077,1896,7966,0186,119
Total Debt
2.971.931.931.93236.43489.93
Net Cash (Debt)
2,1542,2332,4371,769877.01283.39
Net Cash Growth
0.68%-8.37%37.74%101.75%209.48%-
Net Cash Per Share
3.763.884.203.051.530.47
Filing Date Shares Outstanding
566.16569.46583.9594.68576.43592.88
Total Common Shares Outstanding
566.16569.46583.9594.68576.43592.88
Working Capital
1,6491,5512,0331,9491,4211,190
Book Value Per Share
8.337.938.467.997.477.03
Tangible Book Value
4,4524,2844,6834,4643,9633,767
Tangible Book Value Per Share
7.867.528.027.516.876.35
Buildings
-2,4832,4022,4602,3982,385
Machinery
-1,3401,3181,2331,1911,162
Construction In Progress
-472.81227.2598.5482.914.48
Source: S&P Global Market Intelligence. Standard template. Financial Sources.